PREMACURE
Premacure develops and commercializes insulin-like growth factor I (IGF-I) for unmet medical needs for the neonate. It develops IGF-I together with or without its IGFBP-3 natural binding protein for the prevention of complications of preterm birth.
PREMACURE
Industry:
Biotechnology
Founded:
2006-01-01
Address:
Uppsala, Uppsala Lan, Sweden
Country:
Sweden
Website Url:
http://www.premacure.com
Status:
Closed
Contact:
+46 7 06 50 28 52
Email Addresses:
[email protected]
Technology used in webpage:
Domain Not Resolving
More informations about "Premacure"
Premacure - Crunchbase Company Profile & Funding
Premacure develops and commercializes insulin-like growth factor I (IGF-I) for unmet medical needs for the neonate. It develops IGF-I together with or without its IGFBP-3 natural binding …See details»
Premacure 2025 Company Profile: Valuation, Investors ... - PitchBook
When was Premacure founded? Premacure was founded in 2006. Where is Premacure headquartered? Premacure is headquartered in Uppsala, Sweden. What is the size of …See details»
Shire scquires Premacure AB - World Pharma Today
Shire plc has acquired Premacure AB of Uppsala, Sweden, a privately held biotechnology company developing a protein replacement therapy, currently in Phase II development, for the …See details»
Shire Acquires Premacure AB - Takeda
Mar 12, 2013 Premacure AB is a private company launched in 2006 by entrepreneurs and internationally recognized clinicians in the area of neonatology. About ROP Retinopathy of …See details»
Premacure AB - Company Profile and News - Bloomberg Markets
Company profile page for Premacure AB including stock price, company news, executives, board members, and contact informationSee details»
Premacure - Products, Competitors, Financials, Employees, …
Shire buys Premacure AB - European Biotechnology News. Aug 1, 2016. 01.08.2016 Life science venture capital group Epidarex has launched Nodthera Ltd, a biotech based on research by …See details»
Orphanet: PREMACURE AB
PREMACURE AB. institutions.detail.person.activities. Sponsor of orphan designation E-mail: [email protected]. Premacure AB Premacure AB Uppsala Science Park 751 83 UPPSALA …See details»
Shire acquires Premacure - 2013-03-12 - Crunchbase
Mar 12, 2013 Premacure Premacure develops and commercializes insulin-like growth factor I (IGF-I) for unmet medical needs for the neonate. Acquiring Organization: Shire Shire …See details»
Premacure AB:Company Profile & Technical Research,Competitor …
Premacure was founded in 2006. Premacure has a total of 14 patents . Related Topics. Insulin-like growth factor Growth factor Binding protein. Login to view all basic info. Data Snapshot. …See details»
PREEMIES | Lily's Hope Foundation
Lily's Hope accomplishes this by providing resources, aid and hope to families with premature babies through our Preemie Pantry and our Packages of Hope care package programs. ... all-volunteer non-profit organization! Learn More. …See details»
Premacure AB - Drug pipelines, Patents, Clinical trials - Synapse
Explore Premacure AB with its drug pipeline, therapeutic area, technology platform, , Drug:Mecasermin Rinfabate.See details»
Shire acquires Premacure AB - World Pharma News
Mar 12, 2013 Premacure AB is a private company launched in 2006 by entrepreneurs and internationally recognized clinicians in the area of neonatology. About ROP Retinopathy of …See details»
Premacure AB - BioCentury Company Profiles - BCIQ
Jul 11, 2016 Premacure AB - BioCentury Company Profiles for the biopharma industrySee details»
Shire Acquires Premacure AB - PR Newswire
Mar 12, 2013 Premacure AB is a private company launched in 2006 by entrepreneurs and internationally recognized clinicians in the area of neonatology. About ROP. Retinopathy of …See details»
Orphanet: Premacure AB
Premacure AB. Premacure AB. Uppsala Science Park. 751 83 UPPSALA . SWEDEN. Phone 1: 46 (0) 70 650 28 52 Contact email: [email protected]. Institution's website EUGT Number: …See details»
Shire buys Swedish biotech Premacure | pharmaphorum
Mar 15, 2013 Shire acquires Swedish biotech, Premacure, which is in Phase II development of a protein replacement therapy for the prevention of retinopathy of prematurity. Shire has …See details»
Shire Acquires Premacure AB - Pharmaceutical Processing World
Mar 12, 2013 Shire plc, announces that it has acquired Premacure AB of Uppsala, Sweden, a privately held biotechnology company developing a protein replacement therapy, currently in …See details»
Shire acquires Premacure - Nordic Life Science
Mar 27, 2013 Premacure from Uppsala is to be acquired by Shire plc, continuing the development of a new drug to treat a rare eye disorder among premature infants. ... and parts …See details»
Shire acquires Premacure for an undisclosed sum - Manufacturing …
Mar 13, 2013 The acquisition takes Shire into the new area of neonatology – the treatment of sick or premature newborn infants – and expands its focus on developing novel therapies for …See details»
Shire acquires Swiss biotech Premacure - PMLiVE
Mar 13, 2013 Shire HGT will continue Premacure’s ongoing phase II study, the primary goal of which is to restore the IGF-1 levels in the preterm infant to those found during normal in utero …See details»